Fujifilm Life Sciences is a community of scientists and engineers aspiring to accelerate transformative life science breakthroughs that improve human health.
Combining the vast expertise within Fujifilm, life science offerings will accelerate market development and introduction of new technology innovation with the goal of bringing new treatment options to market.
Fujifilm Life Sciences supports all stages and steps of therapeutics development. Together, companies under the Fujifilm Life Science umbrella offer solutions that range from drug discovery tools to commercial manufacturing, covering the entire therapeutics development process.
Company Details
- Employees
- 10
- Founded
- 2018
- Address
- 1 Broadway, Cambridge,ma 02142,united States
- Industry
- Biotechnology
- Keywords
- cell therapies, gene therapies, biopharma, cell culture media, research, life science, drug discovery.
- HQ
- Cambridge, MA
- Competitors
- FUJIFILM Biosciences, Eastman Kodak Company, FUJIFILM Cellular Dynamics, Inc, FUJIFILM Pharmaceuticals U.S.A., Inc., FUJIFILM Corporation, FUJIFILM Holdings America Corporation, FUJIFILM Wako Automation, FUJIFILM Biotechnologies, FUJIFILM Healthcare Americas Corporation, FUJIFILM Data Storage Solutions.
Fujifilm Life Sciences Questions
Fujifilm Life Sciences's website is https://lifesciences.fujifilm.com/
Fujifilm Life Sciences's LinkedIn profile is https://www.linkedin.com/company/fujifilm-life-sciences
Fujifilm Life Sciences has
10 employees.
View email and phone details for 10
employees at Fujifilm Life Sciences.
Fujifilm Life Sciences's industry is
Biotechnology
Fujifilm Life Sciences's top competitors are
Fujifilm Biosciences,
Eastman Kodak Company,
Fujifilm Cellular Dynamics, Inc,
Fujifilm Pharmaceuticals U.s.a., Inc.,
Fujifilm Corporation,
Fujifilm Holdings America Corporation,
Fujifilm Wako Automation,
Fujifilm Biotechnologies,
Fujifilm Healthcare Americas Corporation,
Fujifilm Data Storage Solutions.
Fujifilm Life Sciences's categories are Biotechnology
Fujifilm Life Sciences's founding year is 2018
